HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jafari, H S Articles by Wenger, J D Search for Related Content PubMed PubMed Citation Articles by Jafari, H S Articles by Wenger, J D

Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group.

H S Jafari, W G Adams, K A Robinson, B D Plikaytis and J D Wenger

Childhood and Respiratory Diseases Branch, National Center for Infectious Diseases, Atlanta, Ga., USA.

OBJECTIVES: The purpose of this study was to evaluate the effectiveness of Haemophilus influenzae type b (Hib) conjugate vaccines among children aged 2 to 18 months and to determine risk factors for invasive Hib disease during a period of declining incidence (1991-1994). METHODS: A prospective population-based case-control study was conducted in a multistate US population of 15.5 million. A laboratory-based active surveillance system was used for case detection. RESULTS: In a multivariate analysis, having a single-parent mother (odds ratio [OR] = 4.3, 95% confidence interval [CI] = 1.2, 14.8) and household crowding (OR = 3.5, 95% CI = 1.03, 11.7) were risk factors for Hib disease independent of vaccination status. After adjustment for these risk factors, the protective efficacy of 2 or more Hib vaccine doses was 86% (95% CI = 16%, 98%). Among undervaccinated subjects, living with a smoker (P = .02) and several indicators of lower socioeconomic status were risk factors for Hib disease. CONCLUSIONS: Hib disease still occurs at low levels in the United States, predominantly in socioeconomically disadvantaged populations. Low immunization coverage may facilitate continuing transmission of Hib. Special efforts to achieve complete and timely immunization in disadvantaged populations are needed.

This article has been cited by other articles:

				J McVernon, N Andrews, M Slack, R Moxon, and M Ramsay Host and environmental factors associated with Hib in England, 1998-2002 Arch. Dis. Child., August 1, 2008; 93(8): 670 - 675. [Abstract] [Full Text] [PDF]

				M. J. Donnelly, B. C. Herold, S. G. Jenkins, and R. S. Daum Obstacles to the Elimination of Haemophilus influenzae Type b Disease: Three Illustrative Cases Pediatrics, December 1, 2003; 112(6): 1465 - 1466. [Full Text] [PDF]

				E. Meats, E. J. Feil, S. Stringer, A. J. Cody, R. Goldstein, J. S. Kroll, T. Popovic, and B. G. Spratt Characterization of Encapsulated and Noncapsulated Haemophilus influenzae and Determination of Phylogenetic Relationships by Multilocus Sequence Typing J. Clin. Microbiol., April 1, 2003; 41(4): 1623 - 1636. [Abstract] [Full Text] [PDF]

				X.-Q. Mu, E. H. Egelman, and E. Bullitt Structure and Function of Hib Pili from Haemophilus influenzae Type b J. Bacteriol., September 1, 2002; 184(17): 4868 - 4874. [Abstract] [Full Text] [PDF]

				A. M. Fry, P. Lurie, M. Gidley, S. Schmink, J. Lingappa, M. Fischer, and N. E. Rosenstein Haemophilus influenzae Type b Disease Among Amish Children in Pennsylvania: Reasons for Persistent Disease Pediatrics, October 1, 2001; 108(4): e60 - 60. [Abstract] [Full Text] [PDF]